Latest Publications & Patents on Biotechnology and CRISPR
This week: base editors, gene editing, CRISPR, clinical applications, HOXA1, Bronchial Epithelial, Cell Cycle Progression, p21/CDKN1A, CRISPR/Cas9, Aldehyde Dehydrogenase 1A1,
CRISPR
CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise modifications to DNA sequences within organisms. By utilizing a guide RNA to target specific genetic locations, CRISPR enables researchers to effectively edit genes, facilitating advancements in fields such as biotechnology, medicine, and agriculture. Its potential for innovation in product design and development is vast, offering new avenues for creating genetically engineered organisms with desirable traits and improving therapeutic interventions.
